Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson vs adenosine for stress myocardial perfusion imaging
CTR20170295Phase 3Completed
- Sponsor
- Nanjing Hairong Pharmaceutical Technology
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of regadenoson in cardiac ischemia, sponsored by Nanjing Hairong Pharmaceutical Technology. Started Apr 2017; status: completed.
02
Drugs
regadenoson
03
Conditions
cardiac ischemia
Beyond the preview
Go deeper on CTR20170295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170295.